Abstract
The effects of N-methyl-4-phenylpyridinium cation (MPP+) and of an endogenously formed analog, 2,9-di-methyl-norharmanium cation (2,9-Me2NH+), on extracellular dopamine were studied in the striatum of freely moving rats. Perfusion of either 2,9-Me2NH+ or MPP+ through a microdialysis probe evoked a marked and dose-dependent increase of dopamine levels. Tetrodotoxin and Ca(2+)-free medium prevented the increase in dopamine levels induced by 2,9-Me2NH+, but not that induced by MPP+. Cocaine, 3 microM, intensified the 2,9-Me2 NH(+)-induced increase in extracellular dopamine and slightly attenuated the MPP(+)-induced efflux. S(-)-3-(3-Hydroxy-phenyl)-N-propylpiperidine, that acts as an antagonist of dopamine autoreceptors in the presence of a dopamine reuptake inhibitor, markedly enhanced the increase in extracellular dopamine elicited by 2,9-Me2NH+, but not that by MPP+. These results suggested that 2,9-Me2NH+ was a potent dopamine reuptake blocker, whereas MPP+ acts as an amphetamine-like dopamine releaser rather than a reuptake inhibitor on the membrane transporter.
References
Jan 30, 1992·Brain Research·M A CollinsH Rollema
Aug 1, 1992·Journal of Neurochemistry·K MatsubaraM A Collins
Jan 11, 1991·Brain Research·M SantiagoB H Westerink
Jul 1, 1991·Synapse·D ClarkM P Galloway
Feb 12, 1990·Brain Research·G DruckerM A Collins
Mar 15, 1990·Biochemical Pharmacology·C J CaoM E Eldefrawi
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R AlboresM A Collins
Jan 1, 1990·Life Sciences·P K AroraL M Sayre
Jul 18, 1989·European Journal of Pharmacology·Y L Hurd, U Ungerstedt
Jan 1, 1989·Neuroscience·E CarboniG Di Chiara
May 22, 1989·Neuroscience Letters·R G BoothH Rollema
Jul 4, 1989·European Journal of Pharmacology·E A JohnsonN Castagnoli
Jul 1, 1985·Life Sciences·W J NicklasR E Heikkila
Aug 9, 1988·European Journal of Pharmacology·H RollemaN Castagnoli
Feb 26, 1986·Biochemical and Biophysical Research Communications·R R RamsayT P Singer
Nov 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·B H WesterinkJ B de Vries
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Mar 17, 1987·European Journal of Pharmacology·B H WesterinkH Koning
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J A JavitchS H Snyder
May 16, 1985·Biochemical and Biophysical Research Communications·K ChibaN Castagnoli
Jan 1, 1983·Psychopharmacology·J ArntO Svendsen
Oct 4, 1984·Nature·S P MarkeyM A Herkenham
Feb 25, 1983·Science·J W LangstonI Irwin
Dec 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·R E See
Jan 14, 1994·European Journal of Pharmacology·I SzirákiG Budai
Nov 1, 1993·Carcinogenesis·G A GrossS R Tannenbaum
Aug 10, 1993·European Journal of Pharmacology·M TateyamaH Ono
Apr 30, 1993·Brain Research·K MatsubaraH Shiono
Dec 1, 1995·Neurology·K MatsubaraK Kimura
Oct 1, 1991·Planta medica·H RommelspacherR Susilo
Citations
Jul 3, 1998·European Journal of Pharmacology·K MatsubaraK Kimura
Apr 6, 2001·Neuroscience Letters·K MatsubaraK Kimura
Aug 30, 2002·Neurotoxicology and Teratology·Kazuo MatsubaraToshio Awaya
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mei CuiKim Tieu
Jan 21, 2019·Biomedical Chromatography : BMC·Hiroaki Yamaguchi, Nariyasu Mano
Apr 3, 2010·Pharmacological Reports : PR·Catrin WernickeHans Rommelspacher
Aug 1, 1994·Cephalalgia : an International Journal of Headache·A MayH C Diener